211 related articles for article (PubMed ID: 19519505)
1. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
Lech-Maranda E; Korycka A; Robak T
Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of anti-cancer action and pharmacology of clofarabine.
Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
[TBL] [Abstract][Full Text] [Related]
3. Novel purine nucleoside analogues for hematological malignancies.
Korycka A; Lech-Marańda E; Robak T
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
[TBL] [Abstract][Full Text] [Related]
4. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
Larson ML; Venugopal P
Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
[TBL] [Abstract][Full Text] [Related]
5. Clofarabine: emerging role in leukemias.
Sampat K; Kantarjian H; Borthakur G
Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
[TBL] [Abstract][Full Text] [Related]
6. Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
Kline JP; Larson RA
Expert Opin Pharmacother; 2005 Dec; 6(15):2711-8. PubMed ID: 16316309
[TBL] [Abstract][Full Text] [Related]
7. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927
[TBL] [Abstract][Full Text] [Related]
8. Clofarabine in leukemia.
Ghanem H; Jabbour E; Faderl S; Ghandhi V; Plunkett W; Kantarjian H
Expert Rev Hematol; 2010 Feb; 3(1):15-22. PubMed ID: 21082931
[TBL] [Abstract][Full Text] [Related]
9. Clofarabine in pediatric acute leukemia: current findings and issues.
Hijiya N; Barry E; Arceci RJ
Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
[TBL] [Abstract][Full Text] [Related]
10. The role of clofarabine in acute myeloid leukemia.
Ghanem H; Kantarjian H; Ohanian M; Jabbour E
Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
[TBL] [Abstract][Full Text] [Related]
11. Clofarabine: past, present, and future.
Kantarjian HM; Jeha S; Gandhi V; Wess M; Faderl S
Leuk Lymphoma; 2007 Oct; 48(10):1922-30. PubMed ID: 17852710
[TBL] [Abstract][Full Text] [Related]
12. Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
Bonate PL; Arthaud L; Cantrell WR; Stephenson K; Secrist JA; Weitman S
Nat Rev Drug Discov; 2006 Oct; 5(10):855-63. PubMed ID: 17016426
[TBL] [Abstract][Full Text] [Related]
13. The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
Faderl S; Gandhi V; Keating MJ; Jeha S; Plunkett W; Kantarjian HM
Cancer; 2005 May; 103(10):1985-95. PubMed ID: 15803490
[TBL] [Abstract][Full Text] [Related]
14. Clofarabine.
Drugs R D; 2004; 5(4):213-7. PubMed ID: 15230627
[TBL] [Abstract][Full Text] [Related]
15. Clofarabine in the treatment of myelodysplastic syndromes.
Bryan J; Kantarjian H; Prescott H; Jabbour E
Expert Opin Investig Drugs; 2014 Feb; 23(2):255-63. PubMed ID: 24410313
[TBL] [Abstract][Full Text] [Related]
16. Effect of clofarabine on apoptosis and DNA synthesis in human epithelial colon cancer cells.
Wang X; Albertioni F
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):414-8. PubMed ID: 20544529
[TBL] [Abstract][Full Text] [Related]
17. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR
Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087
[TBL] [Abstract][Full Text] [Related]
18. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
Dressel A; Kwari M; McGreal AM
Clin J Oncol Nurs; 2011 Feb; 15(1):E13-23. PubMed ID: 21278032
[TBL] [Abstract][Full Text] [Related]
19. Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
Larson RA
Semin Oncol; 2007 Dec; 34(6 Suppl 5):S13-20. PubMed ID: 18086342
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
